HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals announced today that two abstracts involving its lead clinical compound GAL-021 were recently recognized among the top scientific abstracts submitted at the 2013 Society of Anesthesia and Sleep Medicine (SASM) Annual Meeting in San Francisco, CA.
Help employers find you! Check out all the jobs and post your resume.
